Literature DB >> 22301433

Reduced miR-31 and let-7 maintain the balance between differentiation and quiescence in lung cancer stem-like side population cells.

Shen Hua1, Xu Xiaotao, Guo Renhua, Yin Yongmei, Liu Lianke, Gao Wen, Shu Yongqian.   

Abstract

Recent studies have indicated that side population (SP) cells, which are an enriched source of cancer stem cells (CSCs), drive and maintain many types of human malignancies. SP cells have distinguishing biological characteristics and are thought to contribute to metastasis, therapy resistance, and tumor recurrence. In the present study, the miRNA expression profiles of SP cells and non-SP cells were compared using miRNA array analysis. Both let-7 and miR-31 were significantly down-regulated in SP cells compared to non-SP cells. The results were confirmed by real-time PCR. Engineered repression of miR-31 caused marked repression of both lung cancer SP cell and non-SP cell growth in vitro. In contrast, engineered repression of let-7 caused marked promotion of both lung cancer SP and non-SP cells growth in vitro. Cell cycle studies further revealed that reduced miR-31 could inhibit SP cell proliferation by a cell cycle arrest in the G0/G1 phase, whereas reduced let-7 induced SP cell proliferation by accelerating G1/S phase transition. Notably, reduced miR-31 prevented SP cell differentiation, whereas reduced let-7 promoted SP cell differentiation under differentiation conditions. These findings indicate that reduced miR-31 and let-7 are involved in maintaining the balance between differentiation and quiescence in SP cells.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22301433     DOI: 10.1016/j.biopha.2011.09.013

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  15 in total

Review 1.  The role of epigenetic regulation in stem cell and cancer biology.

Authors:  Lilian E van Vlerken; Elaine M Hurt; Robert E Hollingsworth
Journal:  J Mol Med (Berl)       Date:  2012-06-02       Impact factor: 4.599

Review 2.  Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers.

Authors:  Bin Bao; Asfar S Azmi; Shadan Ali; Feras Zaiem; Fazlul H Sarkar
Journal:  Ann Transl Med       Date:  2014-06

Review 3.  MicroRNAs targeting prostate cancer stem cells.

Authors:  Yu-Xiang Fang; Yun-Li Chang; Wei-Qiang Gao
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-12

Review 4.  Regulation of miRNAs affects radiobiological response of lung cancer stem cells.

Authors:  Yan-mei Xu; Xing-yun Liao; Xie-wan Chen; De-zhi Li; Jian-guo Sun; Rong-xia Liao
Journal:  Biomed Res Int       Date:  2015-03-01       Impact factor: 3.411

5.  Molecular characterization of the peripheral airway field of cancerization in lung adenocarcinoma.

Authors:  Jun-Chieh J Tsay; Zhiguo Li; Ting-An Yie; Feng Wu; Leopoldo Segal; Alissa K Greenberg; Eric Leibert; Michael D Weiden; Harvey Pass; John Munger; Alexander Statnikov; Kam-Meng Tchou-Wong; William N Rom
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

Review 6.  Regulatory mechanisms of microRNAs in lung cancer stem cells.

Authors:  Tao Fan; Wei Wang; Boyou Zhang; Yao Xu; Lei Chen; Shize Pan; Hao Hu; Qing Geng
Journal:  Springerplus       Date:  2016-10-10

Review 7.  Ovarian cancer stem cells: a new target for cancer therapy.

Authors:  Qinglei Zhan; Chunmei Wang; Saiming Ngai
Journal:  Biomed Res Int       Date:  2013-01-30       Impact factor: 3.411

8.  Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo.

Authors:  Sílvia Cufí; Rosa Bonavia; Alejandro Vazquez-Martin; Cristina Oliveras-Ferraros; Bruna Corominas-Faja; Elisabet Cuyàs; Begoña Martin-Castillo; Enrique Barrajón-Catalán; Joana Visa; Antonio Segura-Carretero; Jorge Joven; Joaquim Bosch-Barrera; Vicente Micol; Javier A Menendez
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

9.  Alteration in Mir-21/PTEN expression modulates gefitinib resistance in non-small cell lung cancer.

Authors:  Hua Shen; Fang Zhu; Jinyuan Liu; Tongpeng Xu; Dong Pei; Rong Wang; Yingying Qian; Qi Li; Lin Wang; Zhumei Shi; Jitai Zheng; Qiudan Chen; Binghua Jiang; Yongqian Shu
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

10.  Prostacyclin reverses the cigarette smoke-induced decrease in pulmonary Frizzled 9 expression through miR-31.

Authors:  M A Tennis; M L New; D G McArthur; D T Merrick; L D Dwyer-Nield; R L Keith
Journal:  Sci Rep       Date:  2016-06-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.